Drostanolone propionate
http://dbpedia.org/resource/Drostanolone_propionate an entity of type: Thing
Drostanolone propionato, o dromostanolone propionato (venduto con i marchi Drolban, Masteril e Masteron) è un farmaco androgeno e steroide anabolizzante (AAS) che è stato usato per trattare il cancro al seno nelle donne, ma non è più commercializzato. Viene somministrato per iniezione nel muscolo.
rdf:langString
Drostanolone propionate, or dromostanolone propionate, sold under the brand names Drolban, Masteril, and Masteron among others, is an androgen and anabolic steroid (AAS) medication which was used to treat breast cancer in women but is now no longer marketed. It is given by injection into muscle. Drostanolone propionate was first described in 1959 and was introduced for medical use in 1961. In addition to its medical use, drostanolone propionate is used to improve physique and performance. The drug is a controlled substance in many countries and so non-medical use is generally illicit.
rdf:langString
rdf:langString
Drostanolone propionate
rdf:langString
Drostanolone propionato
xsd:integer
11229497
xsd:integer
1088618537
rdf:langString
A14
rdf:langString
Intramuscular: 100%
rdf:langString
Oral: 0–2%
xsd:integer
23
xsd:integer
58
xsd:integer
31523
xsd:integer
194604
rdf:langString
DB00858
<second>
172800.0
xsd:integer
36
xsd:integer
-17
rdf:langString
Schedule III
xsd:integer
3
rdf:langString
X
xsd:integer
224004
rdf:langString
CCCO[C@H]1CC[C@@H]2[C@@]1C
xsd:integer
1
rdf:langString
NOTIQUSPUUHHEH-UXOVVSIBSA-N
rdf:langString
Dromostanolone propionate; NSC-12198; Drostanolone 17β-propionate; 2α-Methyl-4,5α-dihydrotestosterone 17β-propionate; 2α-Methyl-DHT propionate; 2α-Methyl-5α-androstan-17β-ol-3-one 17β-propionate
rdf:langString
Drolban, Masteril, Masteron, others
xsd:integer
7
xsd:integer
447772837
xsd:integer
250
rdf:langString
Drostanolone propionate, or dromostanolone propionate, sold under the brand names Drolban, Masteril, and Masteron among others, is an androgen and anabolic steroid (AAS) medication which was used to treat breast cancer in women but is now no longer marketed. It is given by injection into muscle. Side effects of drostanolone propionate include symptoms of masculinization like acne, increased hair growth, voice changes, and increased sexual desire. It has no risk of liver damage. The drug is a synthetic androgen and anabolic steroid and hence is an agonist of the androgen receptor (AR), the biological target of androgens like testosterone and dihydrotestosterone (DHT). It has moderate anabolic effects and weak androgenic effects, which give it a mild side effect profile and make it especially suitable for use in women. The drug has no estrogenic effects. Drostanolone propionate is an androgen ester and a long-lasting prodrug of drostanolone in the body. Drostanolone propionate was first described in 1959 and was introduced for medical use in 1961. In addition to its medical use, drostanolone propionate is used to improve physique and performance. The drug is a controlled substance in many countries and so non-medical use is generally illicit.
rdf:langString
Drostanolone propionato, o dromostanolone propionato (venduto con i marchi Drolban, Masteril e Masteron) è un farmaco androgeno e steroide anabolizzante (AAS) che è stato usato per trattare il cancro al seno nelle donne, ma non è più commercializzato. Viene somministrato per iniezione nel muscolo.
xsd:integer
6947
rdf:langString
Schedule IV
rdf:langString
High
xsd:nonNegativeInteger
16207
rdf:langString
Drolban, Masteril, Masteron, others
xsd:string
58-19-5
xsd:string
31523
xsd:string
DB00858
xsd:string
7DR7H00HDT
xsd:string
224004